195 related articles for article (PubMed ID: 32335390)
1. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
[TBL] [Abstract][Full Text] [Related]
2. Generation of a gene-corrected human iPSC line (CSUASOi004-A-1) from a retinitis pigmentosa patient with heterozygous c.2699 G>A mutation in the PRPF6 gene.
Liang Y; Sun X; Duan C; Zhou Y; Cui Z; Ding C; Gu J; Mao S; Ji S; Chan HF; Tang S; Chen J
Stem Cell Res; 2022 Oct; 64():102911. PubMed ID: 36103774
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation.
Liang Y; Tan F; Sun X; Cui Z; Gu J; Mao S; Chan HF; Tang S; Chen J
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012314
[TBL] [Abstract][Full Text] [Related]
4. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
Li YP; Liu H; Jin ZB
Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
[TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene.
Zhou Y; Ding C; Xia S; Jing Y; Mao S; Liu J; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 Apr; 44():101742. PubMed ID: 32244200
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
13. Using inducible lentiviral vectors to generate induced pluripotent stem cell line ZOCi001-A from peripheral blood cells of a patient with CRB1
Tang X; Liu X; Chen Z; Luo L; Liu X; Deng J; Li DW; Liu Y
Stem Cell Res; 2020 May; 45():101817. PubMed ID: 32387899
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population.
Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP
Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537
[TBL] [Abstract][Full Text] [Related]
17. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
[TBL] [Abstract][Full Text] [Related]
18. Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient.
Wu Y; Zhang T; Chen Z; Tang L; Zhang L; Chen J; Wan X; Sun X
Stem Cell Res; 2024 Apr; 76():103334. PubMed ID: 38340451
[TBL] [Abstract][Full Text] [Related]
19. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene.
Qin Z; Sun L; Sun X; Gao X; Su H
Stem Cell Res; 2021 Mar; 51():102163. PubMed ID: 33450697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
